clinical trial · NCT04040439
Precedex Special Investigation (in Pediatric Patients)
Pfizer·—·completed·n = 111
SedationDexmedetomidine Hydrochloride
brief summary
Secondary Data Collection:To confirm the safety and effectiveness profiles under the actual medical practice of Precedex in Japan.
started
Jul 30, 2019
primary completion
Aug 8, 2022
completion
Aug 8, 2022
last updated
Feb 16, 2024
detailed description
To assess the data, including safety profile, of Precedex Intravenous Solution administered for "sedation during and after mechanical ventilation in the intensive care setting" in pediatric patients under actual medical practice in Japan.
Maruishi Pharmaceutical Co., Ltd. and Pfizer Japan Inc. will collect 50 subjects each.
official title
Precedex(Registered) Intravenous Solution Special Investigation (in Pediatric Patients)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol